N-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxycytidine → N-(1-((2R,3S,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide

Beteiligte Stoffe

Rolle	Name	HCID	Einwaage
Edukt	N-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxycytidine	HCID 2724490	—
Edukt	N4-Benzoyl-2'-deoxy-2'-fluoro-b-D-arabinocytidine	HCID 54266479	—
Produkt	N-(1-((2R,3S,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide	HCID 70700565	—

Reaktionsschritte

This compound is prepared from 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-N4 -benzoylcytosine by the same procedure used for the preparation of N4 -benzoyl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxycytidine.

Herkunft & Nachweise

DOI	10.6084/m9.figshare.5104873.v1
Patentnummer	US05672697
Quelldatensatz	uspto-grants-1997_09
ORD ID	ord-ddf24c9cfde04cab8577c84c8f8c05f3
Quellennotiz	uspto-grants-1997_09